148 related articles for article (PubMed ID: 22115795)
1. Inhibition of Plk1 and Pin1 by 5'-nitro-indirubinoxime suppresses human lung cancer cells.
Yoon HE; Kim SA; Choi HS; Ahn MY; Yoon JH; Ahn SG
Cancer Lett; 2012 Mar; 316(1):97-104. PubMed ID: 22115795
[TBL] [Abstract][Full Text] [Related]
2. 5'-nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells.
Kim SA; Kim SW; Chang S; Yoon JH; Ahn SG
Cancer Lett; 2009 Feb; 274(1):72-7. PubMed ID: 18926623
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells.
Eckerdt F; Yuan J; Saxena K; Martin B; Kappel S; Lindenau C; Kramer A; Naumann S; Daum S; Fischer G; Dikic I; Kaufmann M; Strebhardt K
J Biol Chem; 2005 Nov; 280(44):36575-83. PubMed ID: 16118204
[TBL] [Abstract][Full Text] [Related]
4. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.
Khanal P; Choi HK; Namgoong GM; Ahn SG; Yoon JH; Sohn H; Choi HS
Mol Carcinog; 2011 Dec; 50(12):961-71. PubMed ID: 21400615
[TBL] [Abstract][Full Text] [Related]
5. Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization.
Werwein E; Cibis H; Hess D; Klempnauer KH
Nucleic Acids Res; 2019 Jan; 47(1):103-121. PubMed ID: 30321399
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
Wang Y; Wu L; Yao Y; Lu G; Xu L; Zhou J
Cancer Lett; 2018 Nov; 436():1-9. PubMed ID: 30118839
[TBL] [Abstract][Full Text] [Related]
7. Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition.
Lange L; Hemmerich P; Spänkuch B
Oncotarget; 2015 Sep; 6(28):25801-14. PubMed ID: 26317649
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53.
Van den Bossche J; Deben C; De Pauw I; Lambrechts H; Hermans C; Deschoolmeester V; Jacobs J; Specenier P; Pauwels P; Vermorken JB; Peeters M; Lardon F; Wouters A
Mol Oncol; 2019 May; 13(5):1196-1213. PubMed ID: 30859681
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.
Ferrarotto R; Goonatilake R; Yoo SY; Tong P; Giri U; Peng S; Minna J; Girard L; Wang Y; Wang L; Li L; Diao L; Peng DH; Gibbons DL; Glisson BS; Heymach JV; Wang J; Byers LA; Johnson FM
Clin Cancer Res; 2016 Apr; 22(7):1674-1686. PubMed ID: 26597303
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Lin YC; Sun SH; Wang FF
Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
[TBL] [Abstract][Full Text] [Related]
11. Cep55 stabilization is required for normal execution of cytokinesis.
van der Horst A; Simmons J; Khanna KK
Cell Cycle; 2009 Nov; 8(22):3742-9. PubMed ID: 19855176
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
Yunoki T; Tabuchi Y; Hayashi A; Kondo T
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8353-63. PubMed ID: 24366665
[TBL] [Abstract][Full Text] [Related]
13. Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).
Liu-Sullivan N; Zhang J; Bakleh A; Marchica J; Li J; Siolas D; Laquerre S; Degenhardt YY; Wooster R; Chang K; Hannon GF; Powers S
Oncotarget; 2011 Dec; 2(12):1254-64. PubMed ID: 22248814
[TBL] [Abstract][Full Text] [Related]
14. Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma.
Gerster K; Shi W; Ng B; Yue S; Ito E; Waldron J; Gilbert R; Liu FF
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):253-60. PubMed ID: 20394857
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
16. LSD1 Inhibition Attenuates Tumor Growth by Disrupting PLK1 Mitotic Pathway.
Dalvi PS; Macheleidt IF; Lim SY; Meemboor S; Müller M; Eischeid-Scholz H; Schaefer SC; Buettner R; Klein S; Odenthal M
Mol Cancer Res; 2019 Jun; 17(6):1326-1337. PubMed ID: 30760542
[TBL] [Abstract][Full Text] [Related]
17. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.
Ryo A; Hirai A; Nishi M; Liou YC; Perrem K; Lin SC; Hirano H; Lee SW; Aoki I
J Biol Chem; 2007 Dec; 282(50):36671-81. PubMed ID: 17938171
[TBL] [Abstract][Full Text] [Related]
18. The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas.
Wiegand S; Dakic B; Rath AF; Makarova G; Sterz C; Meissner W; Bette M; Adamkiewicz J; Müller-Brüsselbach S; Müller R; Werner JA; Mandic R
Oral Oncol; 2009 Oct; 45(10):e140-9. PubMed ID: 19502098
[TBL] [Abstract][Full Text] [Related]
19. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
20. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
Choi M; Kim W; Cheon MG; Lee CW; Kim JE
Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
